NVAX Competitors
Novavax, Inc.
$12.64
-$0.18(-1.40%)
60
Overall
60
Value
75
Tech
47
Quality
Market Cap
$2.08B
Volume
8.48M
52W Range
$6.20 - $13.39
Target Price
$13.90
NVAX competitors: SRPT, AGEN, BCRX, EBS, GSK. Novavax, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
NVAX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics, Inc. | $16.83 | $1.78B | $3.27 | - | 50 |
| AGEN Agenus Inc. | $6.50 | $293.55M | $-0.30 | - | 46 |
| BCRX BioCryst Pharmaceuticals, Inc. | $8.05 | $2.06B | $-2.28 | - | 39 |
| EBS Emergent BioSolutions Inc. | $6.91 | $354.30M | $0.13 | - | 57 |
| GSK GSK plc | $47.87 | $94.64B | $4.78 | 3.79% | 33 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVAX | $12.64 | -1.4% | 8.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |